MRVI FY 2020 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

MRVIMaravai LifeSciences Holdings, Inc.

$999M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$284M+98.5% YoY

Gross Profit

$204M72.0% margin

Operating Income

$120M42.2% margin

Net Income

$77M27.1% margin

EPS (Diluted)

$2.36

Cash Flow

Operating Cash Flow

$152M

Free Cash Flow

$127M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.1B

Stockholders' Equity

$89M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$284M	$143M	+98.5%
Gross Profit	$204M	$76M	+168.0%
Operating Income	$120M	$24M	+399.8%
Net Income	$77M	-$8M	+1006.1%